Editor's Choice
RCT | Blood donor’s sex does not impact transfusion recipients’ survival
19 Apr, 2023 | 13:20h | UTCEffect of Donor Sex on Recipient Mortality in Transfusion – New England Journal of Medicine (link to abstract – $ for full-text)
News release: Sex of blood donor has no effect on recipient survival – Ottawa Hospital
Commentary on Twitter
Observational data are conflicting about whether donor sex influences mortality among transfusion recipients. In a multicenter trial in Canada involving 8719 patients, mortality was not influenced by blood-donor sex. https://t.co/54GKPXSXES pic.twitter.com/uYw1KT15py
— NEJM (@NEJM) April 12, 2023
Perspective | Here’s a new data point for cancer patients to consider: ‘time toxicity’
19 Apr, 2023 | 13:18h | UTCHere’s a new data point for cancer patients to consider: ‘time toxicity’ – STAT
Ischemia with nonobstructive coronary artery disease: concept, assessment, and management
19 Apr, 2023 | 13:17h | UTCRelated:
Review: Myocardial infarction with non-obstructive coronary artery disease.
MINOCA from A to Z – American College of Cardiology
Opinion | Universal masking in health care settings: a pandemic strategy whose time has come and gone, for now
18 Apr, 2023 | 13:37h | UTC
Opinion | In-person schooling is essential even during periods of high transmission of COVID-19
18 Apr, 2023 | 13:36h | UTC
Comprehensive clinical practice guidelines for the management of psychiatric emergencies
18 Apr, 2023 | 13:34h | UTCClinical Practice Guidelines for Management of Suicidal Behaviour
Clinical Practice Guidelines for Assessment and Management of Aggressive and Assaultive Behaviour
Clinical Practice Guidelines on Breaking Bad News
Clinical Practice Guidelines for the Use of Electroconvulsive Therapy
Clinical Practice Guidelines for the Use of Transcranial Direct Current Stimulation in Psychiatry
Cluster RCT | Salt substitute outperforms salt restriction in lowering blood pressure in older patients
18 Apr, 2023 | 13:30h | UTCSalt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial – Nature Medicine (if the link is paywalled, try this one)
Commentary: Exploring effectiveness of salt substitutes in elderly care facilities – Medical Xpress
Related:
Salt substitutes vs. regular salt: a quick look.
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis – Heart (link to abstract – $ for full-text)
RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients
Potassium Enriched Salt Substitution Could Prevent a Large Number of Cardiovascular Deaths
Commentary on Twitter
In a cluster-randomized trial in 48 residential elderly care facilities in China, a low-sodium salt substitute instead of regular salt decreased blood pressure and cardiovascular events, while restricting salt consumption did not show beneficial effects https://t.co/Zp0fWH0aA2
— Nature Medicine (@NatureMedicine) April 13, 2023
Study shows approximately half of infectious diseases guideline authors have conflicts of interest with pharmaceutical companies
18 Apr, 2023 | 13:28h | UTC
Review | Management of cardiogenic shock after acute coronary syndromes
18 Apr, 2023 | 13:27h | UTCManagement of cardiogenic shock after acute coronary syndromes – BJA Education
Large-scale study finds genetic causes for 41% of rare pediatric diseases
18 Apr, 2023 | 13:25h | UTCGenomic Diagnosis of Rare Pediatric Disease in the United Kingdom and Ireland – New England Journal of Medicine (free for a limited period)
News Release: 5,500 people diagnosed with rare genetic diseases in major research study – University of Exeter
Commentary on Twitter
The DDD study recruited more than 13,500 families with probands with severe, probably monogenic disorders in the United Kingdom and Ireland and obtained a genetic diagnosis in approximately 41% of probands. https://t.co/W3pfg5HPEZ pic.twitter.com/eGb2yNsGBf
— NEJM (@NEJM) April 12, 2023
Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU
17 Apr, 2023 | 13:19h | UTCGuidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations – Critical Care Medicine (free for a limited period)
Executive Summary: Guidelines for the Management of Adult Acute and Acute-on-Chronic Liver Failure in the ICU: Neurology, Peri-Transplant Medicine, Infectious Disease, and Gastroenterology Considerations – Critical Care Medicine (free for a limited period)
Consensus Paper | Strategies to prevent Clostridioides difficile infections in acute-care hospitals
17 Apr, 2023 | 13:17h | UTCCommentary: New guidance deems antibiotic stewardship essential for preventing C diff infections – CIDRAP
National clinical guideline for stroke for the UK and Ireland
17 Apr, 2023 | 13:15h | UTCNational clinical guideline for stroke for the UK and Ireland – Stroke Working Party (Full PDF here)
RCT | Heterogeneity in blood pressure response to 4 antihypertensive drugs
17 Apr, 2023 | 13:14h | UTCHeterogeneity in Blood Pressure Response to 4 Antihypertensive Drugs: A Randomized Clinical Trial – JAMA (free for a limited period)
News Release: Personalized blood pressure treatment more effective – Uppsala University
Phase 2 RCT | High-dose VE303 reduces recurrent Clostridioides difficile infection rates
17 Apr, 2023 | 13:12h | UTCVE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial – JAMA (free for a limited period)
See also: Visual Abstract
Identifying perioperative anaphylaxis in Japan: epidemiology, allergens, and diagnostic tools
17 Apr, 2023 | 13:10h | UTC
Propofol and survival: an updated meta-analysis of randomized clinical trials
17 Apr, 2023 | 13:09h | UTCPropofol and survival: an updated meta-analysis of randomized clinical trials – Critical Care
Commentary on Twitter (thread – click for more)
Big headline: 252 RCTs looking at more than 30,000 patients show propofol increases mortality compared to ‘other’ (RR 1.10, 95% CI 1.01-1.20, p = 0.03). This translates to an NNH of 235.
Interesting one. Where does the effect stem from? 1/8https://t.co/8z8Z1OE0I3
— Jan Hansel (@VirtueOfNothing) April 14, 2023
Review | Diagnosis and management of prediabetes
12 Apr, 2023 | 13:28h | UTCDiagnosis and Management of Prediabetes: A Review – JAMA (free for a limited period)
Editorial: Prediabetes Diagnosis and Management – JAMA (free for a limited period)
Video: Screening for Prediabetes – JAMA
Audio Clinical Review: Diagnosis and Management of Patients With Prediabetes – JAMA
RCT | Doxycycline postexposure prophylaxis effective in preventing gonorrhea, chlamydia, and syphilis in MSM
12 Apr, 2023 | 13:30h | UTCSummary: In this open-label, randomized study involving 501 men who have sex with men (MSM) and transgender women, researchers investigated the effectiveness of postexposure doxycycline in preventing bacterial sexually transmitted infections (STIs), specifically gonorrhea, chlamydia, and syphilis. Participants with a previous STI in the past year, either taking preexposure prophylaxis (PrEP) against HIV or living with HIV, were randomly assigned to receive 200 mg of doxycycline within 72 hours after condomless sex or standard care without doxycycline. STI testing was performed quarterly, with the primary end point being the incidence of at least one STI per follow-up quarter.
Results demonstrated a significant reduction in STI incidence in both the PrEP and persons living with HIV cohorts who received doxycycline. Overall, the combined incidence of these three STIs was lower by two thirds with doxycycline postexposure prophylaxis compared to standard care. The study also reported five grade 3 adverse events but no serious adverse events attributed to doxycycline. This finding supports the use of doxycycline postexposure prophylaxis among MSM with recent bacterial STIs.
Article: Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Doxycycline after sex found to reduce STI incidence in gay men, transgender women – CIDRAP
Commentary on Twitter
In an open-label, randomized study involving men who have sex with men, doxycycline use after high-risk sexual exposure reduced the incidence of sexually transmitted infections (chlamydia, gonorrhea, and syphilis). https://t.co/tYOj8FLEy2 pic.twitter.com/bzNyvwzYS7
— NEJM (@NEJM) April 5, 2023
RCT | Low-dose olanzapine enhances appetite & weight gain in chemotherapy patients
11 Apr, 2023 | 14:41h | UTCRandomized Double-Blind Placebo-Controlled Study of Olanzapine for Chemotherapy-Related Anorexia in Patients With Locally Advanced or Metastatic Gastric, Hepatopancreaticobiliary, and Lung Cancer – Journal of Clinical Oncology (link to abstract – $ for full-text)
Commentaries:
Low-dose olanzapine improves appetite in chemotherapy patients – MDedge
Commentary on Twitter
This trial is as good as it gets ⭐️⭐️⭐️⭐️⭐️
✅Patient centered supportive care trial
✅Inexpensive medication
✅Conducted in a LMIC
✅Clinically relevant endpoint
✅ Randomized/double-blinded study
✅Potential to immediately change practicehttps://t.co/3nRrFJaS20Kudos!
— Manni Mohyuddin (@ManniMD1) March 29, 2023
Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews
11 Apr, 2023 | 14:39h | UTCRelated:
SR | Nonopioid pharmacological management of acute low back pain
M-A | Limited evidence for analgesic effectiveness in acute low back pain treatment
M-A: Effectiveness of treatments for acute and subacute mechanical non-specific low back pain
Guideline Interventions for the management of acute and chronic low back pain.
M-A: Little benefit from muscle relaxants for adults with non-specific low back pain.
RCT | Exploring the potential of peritumoral lidocaine infiltration to improve outcomes in early breast cancer
11 Apr, 2023 | 14:37h | UTCEffect of Peritumoral Infiltration of Local Anesthetic Before Surgery on Survival in Early Breast Cancer – Journal of Clinical Oncology (link to abstract – $ for full-text)
Blinded, randomized trial of sonographer versus AI cardiac function assessment
11 Apr, 2023 | 14:34h | UTCBlinded, randomized trial of sonographer versus AI cardiac function assessment – Nature
News Release: Is artificial intelligence better at assessing heart health? – Cedars-Sinai Medical Center
ChatGPT et al? Not so fast, say journal editors
11 Apr, 2023 | 14:36h | UTCChatGPT et al? Not So Fast, Say Journal Editors – TCTMD
Related:
AI-Generated Medical Advice—GPT and Beyond – JAMA (free for a limited period)
Chat GPT will change Medicine – Vinay Prasad’s Observations and Thoughts
The use of ChatGPT and other large language models in surgical science – BJS Open
ChatGPT vs. NCI: analyzing the quality of cancer information on myths and misconceptions
Artificial Intelligence in Medicine & ChatGPT: De-Tether the Physician – Journal of Medical Systems (if the link is paywalled, try this one)
Can artificial intelligence help for scientific writing? – Critical Care
Artificial intelligence in academic writing: a paradigm-shifting technological advance
Perspective | ChatGPT-assisted diagnosis: is the future suddenly here?
Perspective | Generating scholarly content with ChatGPT: ethical challenges for medical publishing
ChatGPT: Will It Transform the World of Health Care? – UCSF Department of Medicine
ChatGPT and the future of medical writing (ChatGPT itself wrote this paper)
ChatGPT: five priorities for research – Nature
The path forward for ChatGPT in academia – Lumo’s Newsletter
ChatGPT is fun, but not an author – Science
Tools such as ChatGPT threaten transparent science; here are our ground rules for their use – Nature
ChatGPT listed as author on research papers: many scientists disapprove – Nature
Abstracts written by ChatGPT fool scientists
M-A | Timing of allergenic food introduction and risk of immunoglobulin E–mediated food allergy
11 Apr, 2023 | 14:32h | UTCNews Release: Earlier introduction of allergenic foods in children may prevent food allergies – Imperial College London
Commentary: Allergenic Food Introduction Led to Fewer Allergies, Higher Withdrawal Rate from Intervention – HCP Live
Related:
AAP Updated Recommendations for Dietary Interventions to Prevent Atopic Disease
Timing of introduction of allergenic solids for infants at high risk – Canadian Paediatric Society
Commentary on Twitter
In this study, earlier introduction of multiple allergenic foods was associated with a reduced risk of food allergy but with significant rates of withdrawal from the intervention. https://t.co/lZFkQIH9q7
— JAMA Pediatrics (@JAMAPediatrics) March 27, 2023